Clinical Trials Logo

Brain Injuries, Traumatic clinical trials

View clinical trials related to Brain Injuries, Traumatic.

Filter by:

NCT ID: NCT05426967 Not yet recruiting - Depressive Symptoms Clinical Trials

rTMS for Military TBI-related Depression

ADEPT
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy, safety, and tolerability of two dorsolateral prefrontal cortex (DLPFC) repetitive transcranial magnetic stimulation (rTMS) protocols to alleviate symptoms of depression in United States (U.S.) military service members and veterans with a history of concussion/mild traumatic brain injury (TBI).

NCT ID: NCT05419739 Not yet recruiting - Clinical trials for Brain Injuries, Traumatic

Prognostic Value of Pediatric GCS-Pupil Score in Pediatric Patients With Traumatic Brain Injury

Start date: July 2022
Phase:
Study type: Observational

There are studies reporting that the survival rate in pediatric patients with abnormal pupillary response is 23% and that pupillary response is effective on mortality and patient outcomes. Studies in the literature examining the effect of pupillary response on mortality and outcome in pediatric patients with traumatic brain injury reported that bilaterally dilated pupils were associated with a higher mortality rate. Considering the literature results, we believe that obtaining the GCS-Pupil score by combining GCS and pupillary reaction in pediatric patients with traumatic brain injury will be effective in predicting patient outcomes.

NCT ID: NCT05400343 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Efficacy of Lung and Inferior Vena Cava Sonography for Fluid Optimization

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Traumatic brain injury (TBI) is a leading cause of death and disability in trauma patients. As the primary injury cannot be reversed, management strategies must focus on preventing secondary injury by avoiding hypotension and hypoxia and maintaining appropriate cerebral perfusion pressure (CPP), which is a surrogate for cerebral blood flow (CBF). The goal should be euvolemia and avoidance of hypotension. The assessment of a patient's body fluid status is a challenging task for modern clinicians. The use of Ultrasonography to assess body fluids has numerous advantages. The concept of using lung ultrasound for monitoring the patient is one of the major innovations that emerged from recent studies. Pulmonary congestion may be semiquantified using lung ultrasound and deciding how the patient tolerates fluid. Inferior vena cava (IVC) sonography and point-of-care ultrasound (POCUS) has become widely used as a tool to help clinicians prescribe fluid therapy. Common POCUS applications that serve as guides to fluid administration rely on assessments of the inferior vena cava to estimate preload and lung ultrasound to identify the early presence of extravascular lung water and avoid fluid over resuscitation In this study we will use the measurements of both lung and IVC together to guide fluid dosage in critically ill patients with TBI. We will also use ONSD as a mirror for intra-cranial pressure (ICP).

NCT ID: NCT05340803 Not yet recruiting - Clinical trials for TBI (Traumatic Brain Injury)

Sedation of Ventilated Traumatic Brain Injury Patients With Midazolam Alone Versus Combination With Dexmedetomidine or Magnesium Sulfate; Monitored by Ultrasonograghic Optic Nerve Sheath Diameter

Start date: November 1, 2022
Phase: Phase 3
Study type: Interventional

In TBI, there is a strong correlation between increased ICP and bad outcome. So, appropriate monitoring can be the gold standard in management of TBI. ICP can be measured by invasive and noninvasive methds. One of these noninvasive methods is bedside measurement of optic nerve sheath diameter (ONSD) by ocular ultrasonography

NCT ID: NCT05340114 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Usability Study of CEREBO® - A Novel Non-invasive Intracranial Bleed Detector

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

Traumatic Brain Injury (TBI) is the leading cause of death and disability across the globe. Time from injury to treatment is the most critical factor that determines the patient's recovery. Mild TBI with no apparent symptoms are often left undiagnosed, thus delaying the treatment and hence recovery. CEREBO® is a non-invasive, rapid, near-infrared based, point-of-care device that can detect an intracranial bleed at an early stage.

NCT ID: NCT05327829 Not yet recruiting - Clinical trials for TBI (Traumatic Brain Injury)

Stimulating After Recovery From Traumatic Brain Injury

SMART
Start date: June 30, 2024
Phase: Early Phase 1
Study type: Interventional

This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) and transcutaneous noninvasive vagal nerve stimulation (tnVNS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.

NCT ID: NCT05210855 Not yet recruiting - Closed Head Injury Clinical Trials

Comparison of Image Quality Between Ultra-low Dose (ULD) and Standard Dose CT Scans in Detecting Traumatic Brain Injury in the Emergency Room

ULD-CRANE 2
Start date: March 2022
Phase: N/A
Study type: Interventional

Head trauma is a frequent reason for consultation in the emergency room. The CT scan is the reference examination allowing rapid management of the patient. However, CT examinations are among the diagnostic examinations with the highest exposure to ionizing radiation. The study investigators have previously implemented "ultra-low dose" (ULD) acquisitions for several pathologies with an effective dose level similar to that of a standard radiographic examination. These ULD acquisitions are now routinely used in our clinical practice for explorations of the thorax, spine, pelvis and proximal femurs, extremities. This study expands these ULD acquisitions to skull CT for detecting traumatic intracranial lesions. The study investigators hypothesize that it would be possible to search for intracranial lesions in patients with head trauma using ULD protocols, thereby reducing the doses delivered to the patient while maintaining sufficient image quality for the diagnosis.

NCT ID: NCT05182619 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Stellate Block Versus Nimodipine Infusion for Traumatic Brain Injury

Start date: January 1, 2022
Phase: Early Phase 1
Study type: Interventional

the study is designed to perform an intervention for enhancement of cerebral blood flow in patients with traumatic brain injury showing vasospasm through transcranial doppler

NCT ID: NCT05129514 Not yet recruiting - Trauma, Brain Clinical Trials

Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a course of daily manual lymphatic drainage over the course of 5 days can improve lymphatic drainage function and cognitive outcomes and to determine whether single sessions of manual lymphatic drainage improves lymphatic drainage in moderate to severe traumatic brain injury (TBI) patients.

NCT ID: NCT05051488 Not yet recruiting - Stroke, Acute Clinical Trials

Dynamic Decompressive Craniotomy

Start date: April 30, 2022
Phase:
Study type: Observational

Prospective observational study on patients undergoing decompressive craniotomy